Pharma's Windfall- The mining of rare diseases
Thirty years ago, Congress acted to spur research on rare diseases. Today, we have hundreds of new drugs — along with runaway pricing and market manipulation, as drugmakers turn a law with good intentions into a profit engine.Market manipulation= donating to doctors and patients organizations
(also posted at NN just for the fun of it.)
related post
